Effects of chronic oral treatment with GABA-transaminase inhibitors on the GABA system in brain, liver, kidney, and plasma of the rat

Biochemical Pharmacology

Volumn 52, Issue 9, 1996, Pages 1355-1363

  Qume, Michelle ^a,b   Fowler, Leslie J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

EOS; epilepsy; GABA; GABA T; GAD; GVG

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRATE AMINOTRANSFERASE INHIBITOR; 4 AMINOBUTYRIC ACID; AMINO ACID; ANTICONVULSIVE AGENT; BETA ALANINE; ENZYME INHIBITOR; ETHANOLAMINE SULFATE; GLUTAMATE DECARBOXYLASE; TRANSFERASE INHIBITOR; VIGABATRIN;

ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BODY WEIGHT; BRAIN; CATABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FLUID INTAKE; GABAERGIC SYSTEM; KIDNEY; LIVER; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TISSUE LEVEL; TISSUE SPECIFICITY;

4-AMINOBUTYRATE TRANSAMINASE; ADMINISTRATION, ORAL; ANIMALS; BETA-ALANINE; BRAIN; ENZYME INHIBITORS; ETHANOLAMINES; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; KIDNEY; LIVER; MALE; RATS; RATS, WISTAR; TIME FACTORS; TISSUE DISTRIBUTION; VIGABATRIN;

EID: 0030575875     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00454-6     Document Type: Article

References (57)

1. 1. Tallan HH, Moore S and Stein WH, Studies on the free amino acids and related compounds in the tissues of the cat. J Biol Chem 211: 927-939, 1954.
2. 2. Erdo SL and Bowery NG, GABAergic Mechanisms in the Mammalian Periphery. Raven Press, New York, 1986.
3. 3. Erdo SL, GABA Outside the CNS. Springer-Verlag, New York, 1991.
4. 4. Minuk GY, GABAergic mechanisms and their functional importance in the liver. In: GABAergic Mechanisms in the Mammalian Periphery (Eds. Erdo SL and Bowery NG), pp. 325-337. Raven, New York, 1986.
5. 5. Erdo SL, Dobo E, Parducz A and Wolff JR, Releasable GABA in tubular epithelium of rat kidney. Experentia 47: 227-229, 1991.
6. 6. Oset-Gasque MJ, Launay JM and Gonzalez MP, GABAergic mechanisms in blood cells: their possible role. In: GABAergic Mechanisms in the Mammalian Periphery (Eds. Erdo SL and Bowery NG), pp. 305-324. Raven, New York, 1986.
7. 7. Wu JY, Chude O, Wein J and Roberts E, Glutamate decarboxylase from neural and non-neural tissues. J Neurochem 30: 849-857, 1978.
8. 8. Wu JY, Lin CT, Lin H, Xu Y, Liu JW, Hwang BH and Wei SC, Immunochemical characterization and immunohistochemical localization of glutamate decarboxylase and GABA transaminase in peripheral tissues. In: GABAergic Mechanisms in the Mammalian Periphery (Eds. Erdo SL and Bowery NG), pp. 19-34. Raven, New York, 1986.
9. 9. Andersson AC and Henningson S, In vitro metabolism of putrescine by diamine oxidase in tissues of the pregnant rat. Agents Actions 10: 104-106, 1980.
10. 10. Andersson AC, Henningson S and Jarhult J, Diamine oxidase activity and gamma-aminobutyric acid formation in medullary carcinoma of the thyroid. Agents Actions 10: 299-301, 1980.
11. 11. Caron PC, Kremzner LT and Cote LJ, GABA and its relationship to putrescine metabolism in the rat brain and pancreas. Neurochem Int 10: 219-229, 1987.
12. 12. Fogel WA, GABA and polyamine metabolism in peripheral tissues. In: GABAergic Mechanisms in the Mammalian Periphery (Eds. Erdo SL and Bowery NG), pp. 35-56. Raven, New York, 1986.
13. 13. Krause DN, Involvement of local GABA mechanisms in vascular regulation. In: GABAergic Mechanisms in the Mammalian Periphery (Eds. Erdo SL and Bowery NG), pp. 193-203. Raven, New York, 1986.
14. 14. Zachmann M, Tocci P and Nyhan WL, The occurrence of γ-aminobutyric acid in human tissues other than brain. J Biol Chem 241: 1355-1358, 1966.
15. 15. Waniewski RA and Suria A, Alterations in γ-aminobutyric acid content in the rat superior cervical ganglion and pineal gland. Life Sci 21: 1129-1142, 1977.
16. 16. Ferenci P, Ebner J and Zimmerman C, Overestimation of serum concentrations of γ-aminobutyric acid in patients with hepatic encephalopathy by the γ-aminobutyric acidradioreceptor assay. Hepatology 8: 69-72, 1988.
17. 17. Erdo SL and Kiss B, Presence of GABA, glutamate decarboxylase, and GABA transaminase in peripheral tissues: A collection of quantitative data. In: GABAergic Mechanisms in the Mammalian Periphery (Eds. Erdo SL and Bowery NG), pp. 5-17. Raven Press, New York, 1986.
18. 18. White HL and Sato TL, GABA-transaminases of human brain and peripheral tissues - kinetic and molecular properties. J Neurochem 31: 41-47, 1978.
19. 3H] GABA binding to isolated rat hepatocytes. Am J Physiol 252: 642-647, 1987.
20. 20. Schafer DF, Fowler JM and Jones EA, Hepatic encephalopathy and the γ-aminobutyric acid neurotransmitter system. Lancet 1: 18-19, 1982.
21. 21. Ferenci P, Covell D, Schafer DF, Waggoner JG, Schrager R and Jones AE, Metabolism of the inhibitory neurotransmitter γ-aminobutyric acid in a rabbit model of fulminant hepatic failure. Hepatology 3: 507-512, 1983.
22. 22. Minuk GY, Winder A, Burgess ED and Sarjeant EJ, Serum γ-aminobutyric acid (GABA) levels in patients with hepatic encephalopathy. Hepatogastroenterology 37: 171-174, 1985.
23. 23. Maddison JE, Dodd PR, Johnston GA and Farrell GC, Brain γ-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma γ-aminobutyric acid-like activity. Gostroenterology 93: 1026-1068, 1987.
24. 3H]-muscimol within rat kidney. Pharmacology 36: 390-395, 1988.
25. B receptor sites in rat kidney. Eur J Pharmacol 184: 305-309, 1990.
26. 26. Goodyer PR, Rozen R and Scriver CR, A gamma-aminobutyric acid-specific transport mechanism in mammalian kidney. Biochim Biophys Acta 818: 45-54, 1985.
27. 27. Dobo E, Parducz A, Wolff JR and Erdo SL, Gaba-immunoreactive structures in rat kidney. In: GABA Outside the CNS (Ed. Erdo SL), pp. 155-166. Springer-Verlag, Berlin, 1991.
28. 28. Fowler LJ, Analysis of the major amino acids of rat brain after in vivo inhibition of GABA transaminase by ethanolamine O-sulphate. J Neurochem 21: 437-440, 1973.
29. 29. Jung MJ, Lippert B, Metcalf BW, Bohlen P and Schechter PJ, γ-Vinyl-GABA (4-amino-hex-5-enoic acid), a new selective inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 77: 797-802, 1977.
30. 30. Schechter PJ and Tranier Y, The pharmacology of enzyme-activated inhibitors of GABA-transaminase. In: Enzyme-Activated Irreversible Inhibitors (Eds. Seiler N, Jung MJ and Koch-Weser J), pp. 149-162. Elsevier/North-Holland Press, 1978.
31. 31. Anzelark G, Horton RW, Meldrum BS and Sawaya MCB, Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of γ-amino butyric acid (GABA) in mice with audiogenic seizures. Biochem Pharmacol 25: 413-417, 1976.
32. 32. Fletcher A and Fowler LJ, γ-Aminobutyric acid metabolism in rat brain following chronic oral administration of ethanolamine-O-sulphate. Biochem Pharmacol 29: 1451-1454, 1980.
33. 33. Fowler LJ and John RA, Active site directed irreversible inhibition of 4-aminobutyrate aminotransferase by ethanolamine-O-sulphate in vitro and in vivo. Biochem J 130: 569-573, 1972.
34. 6 (Eds. Korpela T and Christen P), pp. 161-164. Birkhauser Verlag, Basel, 1987.
35. 35. Qume M, Davies J and Fowler JD, Chronic treatment with the GABA transaminase inhibitors ethanolamine-O-sulphate and vigabatrin enhance basal GABA release from cross chopped hippocampal slices. Br J Pharmacol 105: 170P.
36. 36. Phillips NI and Fowler LJ, The effects of sodium valproate on γ-aminobutyrate metabolism and behaviour in naive and ethanolamine O-sulphate pretreated rats and mice. Biochem Pharmacol 31: 2257-2261, 1982.
37. 37. Salvador RA and Albers RW, The distribution of glutamic-gamma-aminobutyric transaminase in the nervous system of the rhesus monkey. J Biol Chem 234: 922-925, 1959.
38. 38. Lowe IP, Robins E and Eyerman GS, The fluorometric measurement of glutamic acid decarboxylase and its distribution in brain. J Neurochem 3: 8-18, 1958.
39. 39. Bradford MM, A rapid and sensitive method for the quantification of microgram quantities of protein utilising the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
40. 40. Lindroth P and Mopper K, High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatisation with opthaldialdehyde. Anal Chem 51: 1667-1674, 1979.
41. 41. Qume M, Whitton PS and Fowler LJ, The effect of chronic treatment with the GABA transaminase inhibitors γ-vinyl GABA and ethanolamine O-sulphate on the in vivo release of GABA from rat hippocampus. J Neurochem 64: 2256-2261, 1995.
42. 42. John RA, Rimmer EM, Williams J, Cole G, Fowler LJ and Richens A, Microvacuolation in rat brains after long term administration of GABA-transaminase inhibitors. Biochem Pharmacol 36: 1467-1473, 1987.
43. 43. Olgiati VR, Netti C, Guidobono F and Pecile A, The central GABAergic system and control of food intake under different experimental conditions. Psychopharmacology 68: 163-167.
44. 44. Zeneroli ML, Iulano E, Racagni G and Baraldi M, Metabolism and brain uptake of γ-aminobutyric acid in galactosamine-induced hepatic encephalopathy in rats. J Neurochem 38: 1219-1222, 1982.
45. 45. Crossley IR and Williams R. Progress in the treatment of chronic porta-systemic encephalopathy. Gut 25: 89-98, 1984.
46. 46. van Gelder N and Elliott KAC, Disposition of γ-aminobutyric acid administered to mammals. J Neurochem 3: 139-143, 1958.
47. 47. Scriver CR, Pueschel S and Davies E, Hyper-β-alaninemia associated with ω-aminoaciduria and β-aminobutyricaciduria, somnolence and seizures. New Engl J Med 274: 635-643, 1966.
48. 48. Perry TL, Kish SJ and Hansen S, Gamma-vinyl-group: effects of chronic administration on the metabolism of group and other amino compounds in the rat brain. J Neurochem 32: 1641-1645, 1979.
49. 49. Schafer DF, Fowler JM and Jones EA, Colonic bacteria: a source of β-aminobutyric acid in blood. Proc Soc Exp Biol Med 167: 301-303, 1981.
50. 50. Bolton JB, Rimmer E, Williams J and Richens A, The effect of vigabatnn on brain and platelet GABA-transaminase activities. Br J Clin Pharmacol 27: 35S-42S, 1989.
51. 51. Loscher W, GABA in plasma and cerebrospinal fluid of different species. Effects of gamma-acetylenic GABA, gamma-vinyl GABA and sodium valproate. J Neurochem 32: 1587-1591, 1979.
52. 52. Schechter PJ, Tranier Y, Jung MJ and Bohlen P, Audiogenic seizure protection by elevated brain GABA concentrations in mice: effects of γ-acetylenic GABA and γ-vinyl GABA, two irreversible GABA-T inhibitors. Eur J Pharmacol 45: 319-328, 1977.
53. 6 Catalysis (Ed. Evangelopoulos AE), pp. 67-75. Alan R. Liss Inc. New York, 1984.
54. 54. Lippert B, Metcalf BW, Jung MJ and Casara P, 4-Amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric acid aminotransferase in mammalian brain. Eur J Biochem 74: 441-445, 1977.
55. 55. Porter TG and Martin DL, Evidence for feedback regulation of glutamate decarboxylase by γ-aminobutyric acid. J Neurochem 43: 1464-1467, 1984.
56. 56. Loscher W, Kretz F-J, Karavius T and Dillinger U, Marked increases of plasma gamma-aminobutyric acid concentrations in cirrhotic patients with portacaval shunts are not associated with alteration of cerebral functions. Digestion 49: 212-220, 1991.
57. 57. Minuk GY, Gauthier T, Gahaire A and Murphy LJ, The effect of GABA on serum and hepatic polyamine concentrations after partial hepatectomy in rats. Hepatology 14: 685-689, 1991.